Latest filing published 15 Jul 2024 for Alivus Life Sciences Limited, €71k.
Filing timeline
BuySaleGlenn Saldanha: trading record in brief
This profile gathers the share dealings of Glenn Saldanha in Alivus Life Sciences Limited. Over a trading history stretching from 15 November 2021 to 11 July 2024, the count stands at 3 filings.
The open-market record is one-sided, with 2 purchases worth €59k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The record was last updated on 15 July 2024 with a transaction (€71k) in Alivus Life Sciences Limited. The last purchase on record was published on 17 November 2021, which is 1,817 days ago. Filings reach the SEBI (PIT + SAST) feed a median of 2 days after the trade. That lag is the time during which only the insider knows about the trade. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Glenn Saldanha
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,800 shares@ ₹829.625154.6% of flowEquity SharesSEBI:8571841e409214e686dc31c1e3d5ec7c00fab77a
- 295 shares@ ₹640.76611.7% of flowEquity SharesSEBI:a844d425e971878fa72024c1c608c4095f1c4b27Canonical exit: 13 Feb 2022 (T+90)
- 7,505 shares@ ₹643.187743.7% of flowEquity SharesSEBI:fedd2ab7716e5bbf7ff3bd5029db25fa1e9c7990Canonical exit: 14 Feb 2022 (T+90)
3 of 3 declarations